Ann: Appendix 4E, page-5

Phillip Morris was willing to pay 7.5 million, this is relevant and gives me confidence that this technology has merit and credit to the sales marketing as it was the biggest order ever.
Who else is willing to pay these type of amounts and what type of demand awaits the pulse.
The cancellation has nothing to do with the tech or Cardiex.From memory it had something to do with vaping but could be wrong.

Regarding reduced lines of costs reduced -
From a previous update-
It is important to acknowledge the significant up-front engineering and development effort that is
required to bring new medical devices to market. As such, as an early-stage growth technology
company, we have a high capital requirement in the current pre-commercialisation phase of the
Company.

Maybe/probably they went to hard and is the reason they had the financial problems they had.However most of those costs are already done.Nasdaq and CES 2021 were way to early,Management got a bit to excited and should just have focused on getting pulse out there.

I think the pulse can be a company maker. One reason - Has any of the Omron devices better features than the pulse? Omron sell approx 2.4 million units per year.Do the math with 5% market share.

I dont place to much faith in conneqt band, but if i see them put in for FDA approval would really start getting quite excited.Would not think they would not submit without a lot of confidence.
Would love to read the thread of the value of this being approved.

Starting to get excited writing this and remember why i invested but then i look at the share price and those seeds of doubt linger.